Benitec Biopharma (NASDAQ:BNTC) has recently captured the attention of investors with a monumental surge in its stock price, boasting a remarkable 205% increase over the past year. This surge is particularly striking given that Benitec, a biotechnology firm focusing on gene therapy, has yet to
Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals and advanced therapy medicinal products (ATMPs), has taken a monumental step towards bolstering its operational capabilities. The German-based company has announced its
Eurofins CDMO Alphora Inc., a contract development and manufacturing organization (CDMO), has recently taken a significant leap in its operational capabilities. The company has unveiled a new Active Pharmaceutical Ingredient (API) manufacturing facility in Mississauga, Canada. This expansion
Roche's recent decision to return the rights to UCB’s anti-tau antibody bepranemab comes after a four-year investment in the Alzheimer's disease drug candidate, which was initially valued at up to $2 billion in milestones. This strategic move happens just before the release of phase 2a d
Additive manufacturing, commonly known as 3D printing, has emerged as a revolutionary technology within the biopharmaceutical industry, offering considerable benefits. One of the most compelling advantages of additive manufacturing is its potential to optimize cleanroom space through the
PureTech Health, a Boston-based biotechnology firm, employs an innovative "hub-and-spoke" model, centralizing resources and expertise to support various offshoot companies focused on specific therapeutic areas or drug-making technologies. This approach aims to merge the strengths of a
